The Board of Trustees of the Leland Stanford Junior University
发明人:
Christopher H. Contag,Stephen H. Thorne
申请号：
US16056152
公开号：
US20190231818A1
申请日:
2018.08.06
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Compositions and methods are provided for the treatment of cancer. An immune effector cell population is pre-infected with an oncolytic virus. The combined therapeutic is safe and highly effective, producing an enhanced anti-tumor effect compared to either therapy alone. The methods of the invention thus provide for a synergistic effect based on the combined biotherapeutics.
